Related Experiment Videos
Immunoglobulin therapy in immunohematological disorders.
V P Choudhry1, M Mahapatra, R Kashyap
1Department of Hematology, All India Institute of Medical Sciences, New Delhi.
Indian Journal of Pediatrics
|April 25, 2000
Summary
Intravenous immunoglobulins (IVIG) are versatile biological factors treating various immune disorders. IVIG is now a preferred therapy for immune-mediated thrombocytopenic purpura, neutropenia, and autoimmune hemolytic anemia.
Area of Science:
- Immunology
- Hematology
Background:
- Immunoglobulins, particularly intravenous immunoglobulins (IVIG), have emerged as significant biological factors with diverse therapeutic applications.
- Initially utilized for primary and secondary immunodeficiency states, IVIG's scope has expanded considerably.
Purpose of the Study:
- To review the structure, pharmacology, and immunoregulation of immunoglobulins.
- To comprehensively examine the application of IVIG in various hematological disorders.
Main Methods:
- Literature review of immunoglobulin structure and function.
- Analysis of clinical data and treatment guidelines for hematological conditions.
Main Results:
- Intravenous immunoglobulins (IVIG) demonstrate broad efficacy across immunohematological, autoimmune, and immunopathological conditions.
- IVIG is recognized as a preferred treatment for immune-mediated thrombocytopenic purpura, neutropenia, and autoimmune hemolytic anemia.
Conclusions:
- Immunoglobulins represent a crucial class of biological agents with expanding therapeutic roles.
- Intravenous immunoglobulins (IVIG) are a cornerstone therapy for specific hematological disorders, offering significant clinical benefits.